| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 220 | $97.84 | 30,250 |
| Feb 25, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 299 | $97.84 | 29,951 |
| Feb 24, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 544 | $94.81 | 30,470 |
| Feb 23, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 1,055 | $96.25 | 31,014 |
| Feb 20, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 1,071 | $100.17 | 32,069 |
| Feb 19, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 5,419 | $99.54 | 33,140 |
| Feb 18, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,527 | -- | 25,069 |
| Feb 18, 2026 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,490 | -- | 38,559 |
| Dec 10, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 223 | $96.64 | 18,845 |
| Dec 10, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 303 | $96.64 | 18,542 |
| Nov 24, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 536 | $96.51 | 19,068 |
| Aug 25, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 547 | $125.31 | 19,604 |
| May 27, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 529 | $114.94 | 20,151 |
| Feb 25, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 4,090 | $105.00 | 21,181 |
| Feb 25, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 501 | $102.45 | 20,680 |
| Feb 24, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 1,048 | $92.90 | 25,271 |
| Feb 20, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 2,387 | $97.28 | 26,319 |
| Feb 19, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,477 | -- | 22,319 |
| Feb 19, 2025 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,387 | -- | 28,706 |
| Nov 25, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 227 | $119.75 | 15,842 |
| Aug 26, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $102.15 | 16,069 |
| Aug 22, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,600 | $87.27 | 18,869 |
| Aug 22, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 2,600 | $101.00 | 16,269 |
| Aug 22, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,610 | $87.27 | 17,879 |
| Aug 22, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 1,610 | $101.00 | 16,269 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.